Teva claws back $50M from former execs, board members to pay for 2016 foreign bribery settlement

When Teva forfeited $519 million to the U.S. government over foreign bribery charges back in 2016, it was meant as a move to clear the drugmaker’s name. Now, Teva is asking former execs and directors to pony up for their end of the agreement.